22-36564694-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006078.5(CACNG2):c.629C>T(p.Ala210Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,936 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006078.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNG2 | NM_006078.5 | c.629C>T | p.Ala210Val | missense_variant | 4/4 | ENST00000300105.7 | |
CACNG2 | NM_001379051.1 | c.560C>T | p.Ala187Val | missense_variant | 5/5 | ||
CACNG2 | XM_017028531.3 | c.371C>T | p.Ala124Val | missense_variant | 3/3 | ||
CACNG2 | NR_166440.1 | n.1995C>T | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNG2 | ENST00000300105.7 | c.629C>T | p.Ala210Val | missense_variant | 4/4 | 1 | NM_006078.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251158Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135808
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461730Hom.: 1 Cov.: 33 AF XY: 0.0000371 AC XY: 27AN XY: 727180
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.629C>T (p.A210V) alteration is located in exon 4 (coding exon 4) of the CACNG2 gene. This alteration results from a C to T substitution at nucleotide position 629, causing the alanine (A) at amino acid position 210 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at